Erufosine
Product Specifications
CAS Number
202867-33-2
Target
Raf, Ras, Akt, p38 MAPK, PI3K
Related Pathways
PI3K/Akt/mTOR signaling, MAPK, Cytoskeletal Signaling
Bioactivity
Erufosine is an inhibitor of the PI3K/Akt and Ras/Raf/MAPK signaling pathways. It suppresses the activity of breast cancer cell lines MCF-7 and MDA-MB 231 with an IC50 of 40.95/40.8 μM, respectively. Erufosine reduces phosphorylation of PI3K (p85), Akt (PKB), and cRaf, making it applicable in research on breast cancer and myeloid leukemia.
Smiles
P(OCCCCCCCCCCCC/C=C\CCCCCCCC)(OCCC[N+](C)(C)C)(=O)[O-]
Molecular Formula
C28H58NO4P
Molecular Weight
503.74
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB1097-500 1x 500 µL
CD44 Standard (HCAM/1097), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
![CD1a Recombinant Rabbit Monoclonal Antibody [JM21-33]](https://cdn.genprice.uk/products/992/68dd1c8c061270361ea81b88/imageurl/et1705-17.webp)
ET1705-17 100 µL
CD1a Recombinant Rabbit Monoclonal Antibody [JM21-33]
Sign In for Pricing
View Details 